AU2003201402B2 - Nutraceuticals for the treatment, protection and restoration of connective tissues - Google Patents
Nutraceuticals for the treatment, protection and restoration of connective tissues Download PDFInfo
- Publication number
- AU2003201402B2 AU2003201402B2 AU2003201402A AU2003201402A AU2003201402B2 AU 2003201402 B2 AU2003201402 B2 AU 2003201402B2 AU 2003201402 A AU2003201402 A AU 2003201402A AU 2003201402 A AU2003201402 A AU 2003201402A AU 2003201402 B2 AU2003201402 B2 AU 2003201402B2
- Authority
- AU
- Australia
- Prior art keywords
- gag
- dna
- peptide complex
- polypeptide
- substantially free
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Mobile Radio Communication Systems (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2003201402A AU2003201402B2 (en) | 2002-01-23 | 2003-01-23 | Nutraceuticals for the treatment, protection and restoration of connective tissues |
| AU2005200614A AU2005200614B2 (en) | 2002-01-23 | 2005-02-11 | Nutraceuticals for the treatment, protection and restoration of connective tissues |
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPS0112 | 2002-01-23 | ||
| AUPS0112A AUPS011202A0 (en) | 2002-01-23 | 2002-01-23 | Nutraceuticals for the treatment, protection and restoration of connective tissues |
| AUPS1054 | 2002-03-12 | ||
| AUPS1054A AUPS105402A0 (en) | 2002-03-12 | 2002-03-12 | Nutraceuticals for the treatment, protection and restoration of connective tissues |
| PCT/AU2003/000061 WO2003062279A1 (en) | 2002-01-23 | 2003-01-23 | Nutraceuticals for the treatment, protection and restoration of connective tissues |
| AU2003201402A AU2003201402B2 (en) | 2002-01-23 | 2003-01-23 | Nutraceuticals for the treatment, protection and restoration of connective tissues |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2005200614A Division AU2005200614B2 (en) | 2002-01-23 | 2005-02-11 | Nutraceuticals for the treatment, protection and restoration of connective tissues |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003201402A1 AU2003201402A1 (en) | 2003-09-18 |
| AU2003201402B2 true AU2003201402B2 (en) | 2004-12-09 |
Family
ID=27614006
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003201402A Ceased AU2003201402B2 (en) | 2002-01-23 | 2003-01-23 | Nutraceuticals for the treatment, protection and restoration of connective tissues |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7371820B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1476471A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2005519914A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2003201402B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2474269A1 (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ534760A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003062279A1 (cg-RX-API-DMAC7.html) |
| ZA (2) | ZA200506610B (cg-RX-API-DMAC7.html) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7067123B2 (en) | 2003-04-29 | 2006-06-27 | Musculoskeletal Transplant Foundation | Glue for cartilage repair |
| AU2003903037A0 (en) | 2003-06-17 | 2003-07-03 | Institute Of Nutraceutical Research | Connective tissue derived polypeptides |
| WO2005067942A1 (en) * | 2004-01-16 | 2005-07-28 | Institute Of Nutraceutical Research Pty Ltd | Glycosaminoglycan peptides derived from connective tissues and use thereof in the prevention of arthritis and other degenerative medical conditions |
| US20090319045A1 (en) | 2004-10-12 | 2009-12-24 | Truncale Katherine G | Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles |
| US7837740B2 (en) | 2007-01-24 | 2010-11-23 | Musculoskeletal Transplant Foundation | Two piece cancellous construct for cartilage repair |
| AU2005202062B2 (en) * | 2005-01-14 | 2012-08-16 | Institute Of Nutraceutical Research Pty Ltd | Nutraceuticals for the treatment, protection, and restoration of connective tissues |
| JP4955944B2 (ja) * | 2005-06-30 | 2012-06-20 | 丸共バイオフーズ株式会社 | コンドロイチン硫酸カルシウム及びその製造方法 |
| WO2007049987A1 (en) * | 2005-10-27 | 2007-05-03 | Savaschuk, Dmitry Alekseevich | Method for producing sulphated glycosaminoglycans from a biological tissues |
| US20080279825A1 (en) | 2007-05-10 | 2008-11-13 | Malinin Theodore I | Cartilage material |
| FR2918376B1 (fr) * | 2007-07-04 | 2011-10-28 | Mathieu Borge | Compositions liquides ou pateuses destinees a l'apport en elements essentiels a la synthese et a la constitution des proteoglycanes, notamment pour le traitement de la degradation du cartilage |
| JP5143621B2 (ja) * | 2008-05-08 | 2013-02-13 | 電気化学工業株式会社 | 哺乳動物由来の生体液試料中のヒアルロン酸の分子量分布の測定方法 |
| FR2938762B1 (fr) * | 2008-11-21 | 2011-02-04 | Oreal | Utilisation cosmetique de proteines de type dj-1 pour le traitement de la secheresse cutanee |
| WO2016111899A1 (en) | 2015-01-05 | 2016-07-14 | Petrucci Gary M | Methods and materials for treating lung disorders |
| WO2016111900A1 (en) * | 2015-01-05 | 2016-07-14 | Petrucci Gary M | Methods and materials for treating arthritis |
| WO2016178945A1 (en) * | 2015-05-01 | 2016-11-10 | The Procter & Gamble Company | Method of improving the appearance of skin and compositions therefor using nicotinamide riboside |
| WO2017004102A1 (en) | 2015-06-29 | 2017-01-05 | The Procter & Gamble Company | Multi-component skin care product comprising nicoinamide riboside in a multi-chambered container |
| KR102114892B1 (ko) | 2016-01-11 | 2020-05-26 | 더 프록터 앤드 갬블 캄파니 | 피부 상태의 치료 방법 및 그를 위한 조성물 |
| US10993969B2 (en) | 2016-02-05 | 2021-05-04 | Gary M. Petrucci | Methods and materials for treating nerve injuries and neurological disorders |
| US10478531B2 (en) | 2017-06-22 | 2019-11-19 | Gary M. Petrucci | Methods and materials for treating blood vessels |
| EP3641725A1 (en) | 2017-06-23 | 2020-04-29 | The Procter and Gamble Company | Composition and method for improving the appearance of skin |
| US10251917B1 (en) | 2017-09-19 | 2019-04-09 | Gary M. Petrucci | Methods and materials for treating tumors |
| US11622963B2 (en) | 2018-07-03 | 2023-04-11 | The Procter & Gamble Company | Method of treating a skin condition |
| CN111235202B (zh) * | 2018-11-29 | 2022-03-08 | 中国中医科学院医学实验中心 | 一种鹿骨蛋白质提取物及其制备方法与应用 |
| US10959933B1 (en) | 2020-06-01 | 2021-03-30 | The Procter & Gamble Company | Low pH skin care composition and methods of using the same |
| CN115843238B (zh) | 2020-06-01 | 2025-06-10 | 宝洁公司 | 改善维生素b3化合物渗透到皮肤中的方法 |
| CN113603762B (zh) * | 2021-08-20 | 2023-06-27 | 吉林农业大学 | 一种花马杂交鹿鹿角盘活性肽及其制备方法和应用 |
| ES2956802B2 (es) * | 2022-05-20 | 2025-10-02 | Bioiberica S A U | Hidrogeles para su uso en ingenieria de tejidos de la piel |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE857389A (fr) * | 1977-08-02 | 1977-12-01 | Marbex Finance Ltd | Procede de preparation de chondroitines-sulfates de metaux alcalins et alcalino-terreux d'un poids moleculaire de 3000 a 6000 |
| CA1302880C (en) | 1986-07-25 | 1992-06-09 | Peter Koepff | Agents for the treatment of arthroses |
| US5399347A (en) | 1987-06-24 | 1995-03-21 | Autoimmune, Inc. | Method of treating rheumatoid arthritis with type II collagen |
| US6147059A (en) * | 1992-02-20 | 2000-11-14 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
| JP3248170B2 (ja) * | 1992-12-11 | 2002-01-21 | マルハ株式会社 | コンドロイチン硫酸蛋白複合体含有食品 |
| US6492349B1 (en) * | 1993-03-31 | 2002-12-10 | Nutramax Laboratories, Inc. | Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue |
| US5364845C1 (en) | 1993-03-31 | 2002-09-10 | Nutramax Lab Inc | Glusosamine chondroitin and manganese composition for the protection and repair of connective tissue |
| AU7205894A (en) * | 1993-06-08 | 1995-01-03 | Neogenix, Inc. | Purified natural and synthetic compounds for the treatment of osteoarthritis |
| EP0873128B1 (en) * | 1996-01-11 | 2004-11-17 | Jagotec Ag | Oral administration of effective amounts of forms of hyaluronic acid |
| TW472045B (en) * | 1996-09-25 | 2002-01-11 | Astra Ab | Protein kinase C inhibitor compounds, method for their preparation, pharmaceutical composition thereof and intermediate used for their preparation |
| US6303585B1 (en) * | 1997-07-03 | 2001-10-16 | Orquest, Inc. | Cross-linked polysaccharide drug carrier |
| US6025327A (en) | 1997-08-08 | 2000-02-15 | Biocell Technology, Llc | Hydrolyzed collagen type II and use thereof |
| US5922692A (en) * | 1998-03-11 | 1999-07-13 | Marino; Richard P. | Concentration of glycosaminoglycans and precursors thereto in food products |
| US6162787A (en) * | 1999-04-02 | 2000-12-19 | Immudyne, Inc. | Methods for treating arthritis using collagen type II, glucosamine chondroitin sulfate, and compositions |
| JP3271008B2 (ja) * | 1999-11-18 | 2002-04-02 | 独立行政法人産業技術総合研究所 | コンドロイチン硫酸類の製造方法 |
| DE10008896A1 (de) * | 2000-02-25 | 2001-08-30 | Beiersdorf Ag | Kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an Benzotriazolderivaten und Alkylnaphthalaten |
| JP2003532681A (ja) * | 2000-05-05 | 2003-11-05 | ジーティーシー バイオセラピューティックス インコーポレイテッド | 遺伝子導入により産生されたデコリン |
| US6924273B2 (en) * | 2000-10-03 | 2005-08-02 | Scott W. Pierce | Chondroprotective/restorative compositions and methods of use thereof |
-
2003
- 2003-01-23 EP EP03700092A patent/EP1476471A4/en not_active Withdrawn
- 2003-01-23 ZA ZA200506610A patent/ZA200506610B/en unknown
- 2003-01-23 WO PCT/AU2003/000061 patent/WO2003062279A1/en not_active Ceased
- 2003-01-23 CA CA002474269A patent/CA2474269A1/en not_active Abandoned
- 2003-01-23 JP JP2003562156A patent/JP2005519914A/ja active Pending
- 2003-01-23 AU AU2003201402A patent/AU2003201402B2/en not_active Ceased
- 2003-01-23 NZ NZ534760A patent/NZ534760A/xx not_active IP Right Cessation
-
2004
- 2004-07-22 US US10/896,546 patent/US7371820B2/en not_active Expired - Fee Related
- 2004-08-19 ZA ZA200406621A patent/ZA200406621B/en unknown
-
2005
- 2005-05-16 US US11/130,470 patent/US7211648B2/en not_active Expired - Fee Related
Non-Patent Citations (3)
| Title |
|---|
| Canadian Agricultural Engineering, Vol. 42, No. 4, 2000, Nakano et al p 205-208 * |
| Journal of Agricultural and Food Chemistry, Vol. 46, No. 2, 1998, Nakano et al, p 772-778 * |
| The Journal of Rheumatology, Vol. 27(2), 2000, Klein et al, p 261-270 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2474269A1 (en) | 2003-07-31 |
| EP1476471A4 (en) | 2005-03-16 |
| US7211648B2 (en) | 2007-05-01 |
| US7371820B2 (en) | 2008-05-13 |
| NZ534760A (en) | 2006-03-31 |
| ZA200406621B (en) | 2005-09-28 |
| US20050020500A1 (en) | 2005-01-27 |
| WO2003062279A1 (en) | 2003-07-31 |
| ZA200506610B (en) | 2006-07-26 |
| JP2005519914A (ja) | 2005-07-07 |
| US20060040851A1 (en) | 2006-02-23 |
| EP1476471A1 (en) | 2004-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7371820B2 (en) | Nutraceuticals for the treatment, protection and restoration of connective tissues | |
| AU2003201402A1 (en) | Nutraceuticals for the treatment, protection and restoration of connective tissues | |
| Rzhepakovsky et al. | Anti‐arthritic effect of chicken embryo tissue hydrolyzate against adjuvant arthritis in rats (X‐ray microtomographic and histopathological analysis) | |
| US20230279048A1 (en) | Compositions containing hc-ha/ptx3 complexes and methods of use thereof | |
| JP3731150B2 (ja) | 軟骨型プロテオグリカンの精製方法 | |
| US7919456B2 (en) | Connective tissue derived polypeptides | |
| WO2020097251A1 (en) | Methods of cellular reprogramming | |
| CA2294090C (en) | Method and product using sturgeon notochord for alleviating the symptoms of arthritis | |
| EP2897974B1 (en) | Use of pedf-derived polypeptides for treating osteoarthritis | |
| Srichamroen et al. | Chondroitin sulfate extraction from broiler chicken cartilage by tissue autolysis | |
| JP2004210715A (ja) | 破骨細胞形成抑制剤 | |
| AU2005200614B2 (en) | Nutraceuticals for the treatment, protection and restoration of connective tissues | |
| NZ547364A (en) | A method for the preparation of a composition comprising residual cartilage tissue particles | |
| US20260125419A1 (en) | Purification methods | |
| Vittayanont et al. | Production of crude chondroitin sulfate from duck trachea. | |
| Nakano et al. | Extraction of aggrecan-peptide from cartilage by tissue autolysis | |
| TW202535436A (zh) | 細胞外囊泡複合物及其用於治療肝臟損傷的用途 | |
| CA2878163C (en) | Compositions containing hc-ha/ptx3 complexes and methods of use thereof | |
| Ghosh et al. | Cartilage derived peptacans: novel nutraceuticals with immunomodulatory, anti-inflammatory and anti-arthritic activities. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |